Insider
| Ticker | Insider | Role | Type | Date | Shares | Price | Value | Notes | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-09-16 | 15,629 | $3.99 | $62,360 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-09-16 | 53,091 | $12.14 | $644,525 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-09-16 | 23,442 | $8.12 | $190,349 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-09-16 | 107,537 | $28.02 | $3,013,187 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-09-16 | 13,398 | $8.46 | $113,347 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-09-16 | 7,869 | $28.57 | $224,817 | Disposed | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sale | 2026-09-15 | 1,195 | $27.00 | $32,265 | Disposed | EDGAR |
| ADPT | OWEN KATEY EINTERZ | Director | Gift | 2026-08-31 | 12,539 | — | — | Disposed | EDGAR |
| ADPT | OWEN KATEY EINTERZ | Director | Sale | 2026-08-26 | 9,615 | $26.00 | $249,990 | Disposed | EDGAR |
| ADPT | HERSHBERG ROBERT | Director | Option exercise | 2026-08-18 | 15,000 | $6.32 | $94,800 | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Option exercise | 2026-08-18 | 278,676 | $6.55 | $1,825,328 | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-08-18 | 278,472 | $24.48 | $6,816,995 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-08-18 | 204 | $25.14 | $5,129 | Disposed | EDGAR |
| ADPT | HERSHBERG ROBERT | Director | Sale | 2026-08-18 | 15,664 | $24.41 | $382,358 | Disposed | EDGAR |
| ADPT | HERSHBERG ROBERT | Director | Sale | 2026-08-18 | 15,000 | $24.39 | $365,850 | Disposed | EDGAR |
| ADPT | NEUPERT PETER M | Director | Sale | 2026-08-17 | 40,000 | $25.10 | $1,004,000 | Disposed | EDGAR |
| ADPT | NEUPERT PETER M | Director | Sale | 2026-08-17 | 15,000 | $25.23 | $378,450 | Disposed | EDGAR |
| ADPT | NEUPERT PETER M | Director | Option exercise | 2026-08-17 | 15,000 | $6.32 | $94,800 | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-08-17 | 318,799 | $25.08 | $7,995,479 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-08-17 | 2,525 | $25.57 | $64,564 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Option exercise | 2026-08-17 | 321,324 | $6.55 | $2,104,672 | Acquired | EDGAR |
| ADPT | NEUPERT PETER M | Director | Sale | 2026-08-17 | 69,690 | $25.16 | $1,753,400 | Disposed | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sale | 2026-08-10 | 3,000 | $25.00 | $75,000 | Disposed | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sale | 2026-07-30 | 1,299 | $24.00 | $31,176 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-07-21 | 278,698 | $21.72 | $6,053,321 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-07-21 | 213,702 | $22.12 | $4,727,088 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Option exercise | 2026-07-21 | 284,800 | $6.55 | $1,865,440 | Acquired | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sale | 2026-07-16 | 5,000 | $23.00 | $115,000 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-07-15 | 105,762 | $22.59 | $2,389,164 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-07-15 | 22,711 | $8.46 | $192,135 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-07-15 | 59,374 | $7.80 | $463,117 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-07-15 | 23,677 | $12.14 | $287,439 | Acquired | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-07-02 | 146,889 | $22.45 | $3,297,658 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-07-02 | 239,351 | $21.74 | $5,203,491 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-07-02 | 44,838 | $22.59 | $1,012,890 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-07-02 | 12,626 | $7.80 | $98,483 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-07-02 | 12,600 | $12.14 | $152,964 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-07-02 | 12,637 | $8.46 | $106,909 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-07-01 | 3,500 | $7.80 | $27,300 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-07-01 | 8,743 | $22.18 | $193,920 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-07-01 | 42,261 | $22.50 | $950,872 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-07-01 | 4,688 | $3.99 | $18,705 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-07-01 | 12,206 | $8.46 | $103,263 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-07-01 | 3,300 | $12.14 | $40,062 | Acquired | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sale | 2026-07-01 | 487 | $22.00 | $10,714 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-07-01 | 14,064 | $8.12 | $114,200 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2026-06-29 | 51,570 | $8.12 | $418,748 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sale | 2026-06-29 | 154,768 | $21.14 | $3,271,796 | Disposed | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2026-06-29 | 1,837 | $12.14 | $22,301 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2026-06-29 | 24,944 | $8.46 | $211,026 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2026-06-26 | 11,034 | $12.14 | $133,953 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sale | 2026-06-26 | 11,034 | $21.00 | $231,714 | Disposed | EDGAR |
| ADPT | GRIFFIN MICHELLE RENEE | Director | Sale | 2026-06-25 | 52,084 | $20.18 | $1,051,055 | Disposed | EDGAR |
| ADPT | GRIFFIN MICHELLE RENEE | Director | Option exercise | 2026-06-25 | 52,084 | $7.80 | $406,255 | Acquired | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sale | 2026-06-25 | 5,000 | $20.50 | $102,500 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-06-16 | 6,160 | $18.01 | $110,942 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-06-15 | 100,000 | $17.37 | $1,737,000 | Disposed | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sale | 2026-06-11 | 5,000 | $19.00 | $95,000 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-06-04 | 5,792 | $12.14 | $70,315 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-06-04 | 2,344 | $3.99 | $9,353 | Acquired | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sale | 2026-06-04 | 11,000 | $18.00 | $198,000 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-06-04 | 39,741 | $17.49 | $695,070 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-06-04 | 9,376 | $8.12 | $76,133 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-06-04 | 2,009 | $8.46 | $16,996 | Acquired | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Sale | 2026-05-18 | 3,115 | $13.04 | $40,620 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-27 | 19,037 | $14.23 | $270,897 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-27 | 14,707 | $8.46 | $124,421 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-24 | 14,722 | $8.46 | $124,548 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-24 | 19,060 | $14.02 | $267,221 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-23 | 19,060 | $13.74 | $261,884 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-23 | 14,722 | $8.46 | $124,548 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-22 | 19,060 | $14.13 | $269,318 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-22 | 14,722 | $8.46 | $124,548 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-21 | 14,722 | $8.46 | $124,548 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-21 | 30,941 | $14.66 | $453,595 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-21 | 11,881 | $12.14 | $144,235 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-20 | 14,722 | $8.46 | $124,548 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-20 | 19,060 | $14.55 | $277,323 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-17 | 19,060 | $14.57 | $277,704 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-17 | 14,722 | $8.46 | $124,548 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-16 | 19,060 | $14.18 | $270,271 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-16 | 14,722 | $8.46 | $124,548 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-15 | 14,722 | $8.46 | $124,548 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-15 | 19,060 | $14.61 | $278,467 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-14 | 19,060 | $14.56 | $277,514 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-14 | 14,722 | $8.46 | $124,548 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-13 | 6,613 | $8.46 | $55,946 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-13 | 3,338 | $14.08 | $46,999 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-13 | 15,722 | $12.95 | $203,600 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-13 | 8,109 | $7.27 | $58,952 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-10 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-10 | 400 | $13.48 | $5,392 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-10 | 18,660 | $12.75 | $237,915 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-09 | 2,100 | $14.44 | $30,324 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-09 | 16,960 | $13.79 | $233,878 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-09 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-04-08 | 2,344 | $3.99 | $9,353 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-08 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-08 | 11,881 | $12.14 | $144,235 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-08 | 30,841 | $14.83 | $457,372 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-08 | 100 | $15.48 | $1,548 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-04-08 | 10,000 | $14.85 | $148,500 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-04-08 | 37,263 | $15.19 | $566,025 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-04-08 | 22,564 | $15.07 | $340,039 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-07 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-07 | 19,060 | $13.56 | $258,454 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-06 | 19,060 | $14.33 | $273,130 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-06 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-04-06 | 83,332 | $14.41 | $1,200,814 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-02 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-02 | 19,060 | $14.60 | $278,276 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-04-01 | 19,060 | $14.45 | $275,417 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-04-01 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-31 | 19,060 | $13.45 | $256,357 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-31 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-30 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-30 | 19,060 | $12.63 | $240,728 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-27 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-27 | 16,322 | $13.48 | $220,021 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-27 | 2,738 | $12.49 | $34,198 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-26 | 19,060 | $14.12 | $269,127 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-26 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-25 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-25 | 19,060 | $14.27 | $271,986 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-24 | 19,060 | $13.70 | $261,122 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-24 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-23 | 19,060 | $13.83 | $263,600 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-23 | 14,722 | $7.27 | $107,029 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-20 | 19,060 | $13.37 | $254,832 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-20 | 3,939 | $6.55 | $25,800 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-20 | 10,783 | $7.27 | $78,392 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-19 | 19,060 | $13.18 | $251,211 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-19 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-18 | 19,060 | $13.18 | $251,211 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-18 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-17 | 19,060 | $13.40 | $255,404 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-17 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-16 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-16 | 19,060 | $13.41 | $255,595 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-13 | 19,060 | $12.96 | $247,018 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-13 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-12 | 5,400 | $13.43 | $72,522 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-12 | 13,660 | $12.63 | $172,526 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-12 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-11 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Sale | 2026-03-11 | 18,672 | $13.17 | $245,910 | Disposed | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sale | 2026-03-11 | 41,338 | $13.17 | $544,421 | Disposed | EDGAR |
| ADPT | GRIFFIN MICHELLE RENEE | Director | Sale | 2026-03-11 | 15,394 | $13.91 | $214,131 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-03-11 | 140,666 | $13.17 | $1,852,571 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-03-11 | 329,600 | $13.17 | $4,340,832 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-11 | 122,523 | $13.17 | $1,613,628 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-03-11 | 329,600 | $13.17 | $4,340,832 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-03-11 | 140,567 | $13.17 | $1,851,267 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-03-11 | 30,593 | $14.08 | $430,749 | Disposed | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sale | 2026-03-11 | 63,103 | $13.17 | $831,067 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-11 | 19,060 | $14.08 | $268,365 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-10 | 19,460 | $14.68 | $285,673 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-10 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-10 | 400 | $12.14 | $4,856 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-09 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-09 | 30,941 | $14.79 | $457,617 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-09 | 11,881 | $12.14 | $144,235 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-06 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Award | 2026-03-06 | 709,220 | — | — | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-06 | 30,941 | $15.14 | $468,447 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-06 | 11,881 | $12.14 | $144,235 | Acquired | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Award | 2026-03-06 | 709,220 | — | — | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-05 | 11,881 | $12.14 | $144,235 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-05 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-03-05 | 38,074 | $15.09 | $574,537 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-05 | 30,941 | $16.00 | $495,056 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Award | 2026-03-04 | 127,813 | — | — | Acquired | EDGAR |
| ADPT | NEUPERT PETER M | Director | Award | 2026-03-04 | 15,625 | — | — | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Award | 2026-03-04 | 81,250 | — | — | Acquired | EDGAR |
| ADPT | HERSHBERG ROBERT | Director | Award | 2026-03-04 | 15,625 | — | — | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Award | 2026-03-04 | 44,063 | — | — | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Award | 2026-03-04 | 39,063 | — | — | Acquired | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Award | 2026-03-04 | 59,375 | — | — | Acquired | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Award | 2026-03-04 | 62,500 | — | — | Acquired | EDGAR |
| ADPT | OWEN KATEY EINTERZ | Director | Award | 2026-03-04 | 15,625 | — | — | Acquired | EDGAR |
| ADPT | GRIFFIN MICHELLE RENEE | Director | Award | 2026-03-04 | 15,625 | — | — | Acquired | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Award | 2026-03-04 | 61,875 | — | — | Acquired | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Award | 2026-03-04 | 127,813 | — | — | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-04 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-04 | 11,881 | $12.14 | $144,235 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-04 | 30,941 | $16.60 | $513,621 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-03-03 | 50,703 | $15.49 | $785,389 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-03 | 14,722 | $6.55 | $96,429 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Option exercise | 2026-03-03 | 11,881 | $12.14 | $144,235 | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-03 | 24,423 | $15.49 | $378,312 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2026-03-03 | 6,518 | $16.33 | $106,439 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-03-03 | 14,233 | $16.52 | $235,129 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-03-03 | 2,380 | $16.15 | $38,437 | Disposed | EDGAR |
| ADPT | GRIFFIN MICHELLE RENEE | Director | Option exercise | 2026-03-03 | 48,044 | $3.99 | $191,696 | Acquired | EDGAR |
| ADPT | GRIFFIN MICHELLE RENEE | Director | Sale | 2026-03-03 | 48,044 | $15.30 | $735,073 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-03-02 | 289,024 | $15.82 | $4,572,360 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-03-02 | 10,000 | $15.72 | $157,200 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-02-27 | 182,891 | $15.99 | $2,924,427 | Disposed | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Sale | 2026-02-04 | 2,145 | $18.46 | $39,597 | Disposed | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Option exercise | 2026-02-04 | 2,145 | $12.14 | $26,040 | Acquired | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-02-03 | 8,120 | $19.00 | $154,280 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-02-02 | 34,668 | $18.60 | $644,825 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-02-02 | 124,998 | $18.44 | $2,304,963 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-01-12 | 7,723 | $12.14 | $93,757 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-01-12 | 79,590 | $17.73 | $1,411,131 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-01-12 | 14,215 | $3.99 | $56,718 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-01-12 | 21,002 | $8.46 | $177,677 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-01-12 | 36,650 | $7.80 | $285,870 | Acquired | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Option exercise | 2026-01-12 | 4,290 | $12.14 | $52,081 | Acquired | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Sale | 2026-01-12 | 4,290 | $18.00 | $77,220 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2026-01-06 | 10,000 | $16.44 | $164,400 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2026-01-05 | 124,998 | $15.59 | $1,948,719 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2026-01-02 | 3,125 | $3.99 | $12,469 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2026-01-02 | 3,125 | $16.08 | $50,250 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2025-12-22 | 1,100 | $7.80 | $8,580 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2025-12-22 | 2,194 | $8.46 | $18,561 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2025-12-22 | 4,394 | $17.50 | $76,895 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2025-12-15 | 39,849 | $3.99 | $158,998 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2025-12-15 | 113,890 | $15.57 | $1,773,267 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2025-12-15 | 37,750 | $7.80 | $294,450 | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Option exercise | 2025-12-15 | 19,423 | $8.46 | $164,319 | Acquired | EDGAR |
| ADPT | HERSHBERG ROBERT | Director | Sale | 2025-12-10 | 22,968 | $16.00 | $367,488 | Disposed | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sale | 2025-12-04 | 12,604 | $16.85 | $212,377 | Disposed | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2025-12-04 | 4,157 | $8.46 | $35,168 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2025-12-04 | 4,290 | $12.14 | $52,081 | Acquired | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2025-12-04 | 10,000 | $16.61 | $166,100 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2025-12-03 | 27,212 | $18.61 | $506,415 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-12-01 | 124,998 | $18.94 | $2,367,462 | Disposed | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Option exercise | 2025-11-28 | 11,980 | $6.55 | $78,469 | Acquired | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Option exercise | 2025-11-28 | 94,384 | $12.14 | $1,145,822 | Acquired | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Option exercise | 2025-11-28 | 3,750 | $7.80 | $29,250 | Acquired | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Sale | 2025-11-28 | 162,820 | $19.50 | $3,174,990 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-11-26 | 35,736 | $19.68 | $703,284 | Disposed | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2025-11-21 | 119,809 | $12.14 | $1,454,481 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2025-11-21 | 34,375 | $7.27 | $249,906 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2025-11-21 | 49,480 | $6.55 | $324,094 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2025-11-21 | 20,834 | $6.55 | $136,463 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sale | 2025-11-21 | 308,477 | $16.91 | $5,216,346 | Disposed | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2025-11-21 | 834 | $6.27 | $5,229 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2025-11-21 | 83,145 | $3.99 | $331,749 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2025-11-20 | 133,032 | $8.46 | $1,125,451 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Option exercise | 2025-11-20 | 68,961 | $12.14 | $837,187 | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sale | 2025-11-20 | 297,925 | $16.54 | $4,927,680 | Disposed | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Sale | 2025-11-17 | 238 | $14.05 | $3,344 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-11-12 | 1,867 | $15.00 | $28,005 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-11-11 | 1,237 | $14.57 | $18,023 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-11-10 | 86,161 | $14.73 | $1,269,152 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2025-11-10 | 10,000 | $14.82 | $148,200 | Disposed | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Sale | 2025-05-16 | 1,929 | $8.89 | $17,149 | Disposed | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Award | 2025-05-15 | 7,815 | — | — | Acquired | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Option exercise | 2025-05-01 | 68,412 | $6.32 | $432,364 | Acquired | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2025-05-01 | 68,412 | $7.35 | $502,828 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Option exercise | 2025-03-24 | 1,698 | $6.32 | $10,731 | Acquired | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2025-03-24 | 1,698 | $9.00 | $15,282 | Disposed | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Option exercise | 2025-03-14 | 2,500 | $6.32 | $15,800 | Acquired | EDGAR |
| ADPT | GRIFFIN MICHELLE RENEE | Director | Sale | 2025-03-13 | 36,291 | $7.19 | $260,932 | Disposed | EDGAR |
| ADPT | HERSHBERG ROBERT | Director | Sale | 2025-03-12 | 53,000 | $7.59 | $402,270 | Disposed | EDGAR |
| ADPT | NEUPERT PETER M | Director | Sale | 2025-03-10 | 10,000 | $7.05 | $70,500 | Disposed | EDGAR |
| ADPT | NEUPERT PETER M | Director | Option exercise | 2025-03-10 | 50,000 | $4.07 | $203,500 | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-03-06 | 102,218 | $7.64 | $780,946 | Disposed | EDGAR |
| ADPT | GRIFFIN MICHELLE RENEE | Director | Sale | 2025-03-06 | 15,664 | $7.94 | $124,372 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-03-05 | 81,206 | $6.98 | $566,818 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2025-03-05 | 7,085 | $6.98 | $49,453 | Disposed | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Sale | 2025-03-05 | 13,790 | $6.99 | $96,392 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2025-03-05 | 40,603 | $6.98 | $283,409 | Disposed | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sale | 2025-03-05 | 56,053 | $6.99 | $391,810 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Award | 2025-03-05 | 247,117 | — | — | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-03-05 | 36,145 | $6.99 | $252,654 | Disposed | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Sale | 2025-03-05 | 26,023 | $6.98 | $181,641 | Disposed | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sale | 2025-03-05 | 41,600 | $6.98 | $290,368 | Disposed | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Sale | 2025-03-05 | 3,065 | $6.99 | $21,424 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2025-03-05 | 19,461 | $6.99 | $136,032 | Disposed | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Sale | 2025-03-05 | 40,044 | $6.98 | $279,507 | Disposed | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Sale | 2025-03-05 | 3,103 | $6.97 | $21,628 | Disposed | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Sale | 2025-03-05 | 253 | $6.98 | $1,766 | Disposed | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Sale | 2025-03-05 | 6,964 | $6.99 | $48,678 | Disposed | EDGAR |
| ADPT | NEUPERT PETER M | Director | Award | 2025-03-04 | 15,394 | — | — | Acquired | EDGAR |
| ADPT | RUBINSTEIN JULIE | President and COO | Award | 2025-03-04 | 175,000 | — | — | Acquired | EDGAR |
| ADPT | Pellini Michael J | Director | Award | 2025-03-04 | 15,394 | — | — | Acquired | EDGAR |
| ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | Award | 2025-03-04 | 109,973 | — | — | Acquired | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Award | 2025-03-04 | 119,971 | — | — | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Award | 2025-03-04 | 355,000 | — | — | Acquired | EDGAR |
| ADPT | HERSHBERG ROBERT | Director | Award | 2025-03-04 | 15,394 | — | — | Acquired | EDGAR |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Award | 2025-03-04 | 355,000 | — | — | Acquired | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Award | 2025-03-04 | 125,000 | — | — | Acquired | EDGAR |
| ADPT | LO FRANCIS | Chief People Officer | Award | 2025-03-04 | 99,976 | — | — | Acquired | EDGAR |
| ADPT | GRIFFIN MICHELLE RENEE | Director | Award | 2025-03-04 | 15,394 | — | — | Acquired | EDGAR |
| ADPT | OWEN KATEY EINTERZ | Director | Award | 2025-03-04 | 15,394 | — | — | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Option exercise | 2025-02-20 | 99,107 | $6.32 | $626,356 | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-02-20 | 99,107 | $8.44 | $836,463 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Option exercise | 2025-02-19 | 186,080 | $6.32 | $1,176,026 | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-02-19 | 186,080 | $8.46 | $1,574,237 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-02-18 | 211,160 | $8.50 | $1,794,860 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Option exercise | 2025-02-18 | 211,160 | $6.32 | $1,334,531 | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Option exercise | 2025-02-14 | 158,921 | $6.32 | $1,004,381 | Acquired | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-02-14 | 158,921 | $8.46 | $1,344,472 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Sale | 2025-02-13 | 100,287 | $8.44 | $846,422 | Disposed | EDGAR |
| ADPT | ROBINS CHAD M | CEO and Chairman | Option exercise | 2025-02-13 | 100,287 | $6.32 | $633,814 | Acquired | EDGAR |
| ADPT | PISKEL KYLE | Chief Financial Officer | Sale | 2024-11-18 | 248 | $4.98 | $1,235 | Disposed | EDGAR |
| ADPT | BOBULSKY SUSAN | Chief Commercial Officer, MRD | Option exercise | 2024-10-08 | 5,000 | $1.98 | $9,900 | Acquired | EDGAR |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status